top of page

When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients

Writer's picture: Women's Cancer Research FoundationWomen's Cancer Research Foundation

Updated: Jan 12, 2024


PERATING ROOM LIGHTS

In many patients with ovarian cancer, the disease eventually recurs after initial treatment with surgery and chemotherapy. When ovarian cancer does recur, patients may have additional surgery to remove as much of the cancer as possible before starting chemotherapy again.

However, it is unclear whether this additional or secondary surgery improves patient survival.


Not all patients can tolerate a secondary surgery.

A recent clinical trial revealed that a secondary surgery followed by chemotherapy can improve survival compared to chemotherapy alone. The DESKTOP III clinical trial enrolled 407 people with recurrent ovarian cancer, nearly all of whom had received chemotherapy after their initial diagnosis. All participants were treated at specialized medical centers. The subjects were randomly assigned to receive either surgery followed by chemotherapy or chemotherapy alone. The patients in the surgery and chemotherapy group lived for a median of 54 months after starting treatment, compared with 46 months in the chemotherapy alone group.


Although not all patients can tolerate a secondary surgery, the results of the DESKTOP III study indicate that surgery should be considered when endeavoring to achieve the best results in the management of recurrent ovarian cancer.


More Ovarian Cancer Information:



About Women’s Cancer Research Foundation


The Women’s Cancer Research Foundation (WCRF) is one of the most active research organizations in the nation. We are dedicated to studying and evaluating novel treatments for women afflicted with breast, ovarian, endometrial, and cervical cancers. The WCRF persistently endeavors to make a difference in women’s lives by offering them hope, strength, and progress.



Laguna Beach, CA 92651

PH: (949) 642-5165


Follow Us On Social Media:






44 views0 comments

コメント


FORMERLY KNOWN AS THE NANCY YEARY WOMEN'S CANCER RESEARCH FOUNDATION
IN MEMORY OF NANCY AND BOB YEARY

ABOUT US 

Since 1985, the physicians and researchers at the WCRF have been at the forefront of pioneering clinical research, aimed at enhancing cure rates among women diagnosed with breast, ovarian, uterine, and cervical cancers. WCRF actively engages in designing, conducting, and disseminating groundbreaking research focused on cutting-edge medical treatments.


Furthermore, WCRF serves as a vital hub for both foundational and applied research, as well as education, pertaining to the latest advancements in the treatment of breast and gynecologic cancers. In addition to conducting and publishing original research, the WCRF, provides valuable clinical information to physicians and patients alike.
 

 

Subscribe to Our Newsletter

Thanks for submitting!

CONTACT 

T: 949-642-5165

F: 949-646-7157

​

​

699 Diamond Street
Laguna Beach, CA 92651

  • Womens Cancer Research Foundation on X
  • LinkedIn
  • Facebook
  • YouTube
  • Instagram
Wpmen's Cancer Research Foundation

© 2025 Women's Cancer Research Foundation All rights reserved.

Website design by Tribe of Digital Natives

bottom of page